Overview

Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis (0476-297)

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to look at the preliminary safety profile of an investigational drug in children 1 to < 3 months of age with bronchiolitis.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast
Criteria
Inclusion Criteria :

- Active bronchiolitis and a history of bronchiolitis and asthma-like symptoms.

Exclusion Criteria :

- Anemia or history of any significant illness that will pose additional risk to the
patient.